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Regulation of the G1/S transition phase in mesangial cells by ered critical for the passage of cells through G1 and into
E2F1. It has been established that E2F transcription factors S phase. The E2F transcription factor regulates cell cycle
are essential for the regulation of the cell cycle. The E2Fs play progression by influencing the expression of protein re-an important role in G1/S transition phase, as they regulate
quired for the G1/S transition phase and DNA synthesis.the activation of several genes whose products are required
The E2F family ordinarily exists in complexes with thefor DNA synthesis. E2Fs bind to the retinoblastoma protein
family and their transcriptional activities are suppressed in the Rb tumor suppresser family (pRb, p107, and p130) and
G0 and early G1 phases. The E2F family consists of a group suppresses their transcriptional activity [1, 2]. It is gener-
of five closely related proteins (E2F1 through E2F5). Prolifera-
ally believed that the cyclin D/cyclin dependent kinasetion of the mesangial cell is a common feature of many glomeru-
(CDK) complex facilitates phosphorylation of Rb familylar diseases, but the regulation of mesangial cell cycle has not
been clarified, nor has the participation of the E2F family in proteins with the release of E2F by mitogenic stimulation
mesangial cells. To elucidate the mechanisms of G1/S transition [3]. The free E2F, which is present as a heterodimer with
phase in mesangial cells, we investigated the roles of the E2F its binding partner DP-1 or DP-2 [4, 5], is an activefamily in the mesangial cell cycle. In primary cultured mesan-
transcription factor that promotes the transcription ofgial cells, the protein expression of E2F1 through E2F3 was
induced by fetal calf serum (FCS) stimulation. E2F1 especially target genes containing the E2F binding site within their
was strongly induced by mitogenic stimulation. The E2F4 pro- promoter region [6]. Interaction with pRb not only pre-
tein was abundantly expressed in the quiescent state and was vents E2F binding to the target sequences, but silences
slightly increased by FCS stimulation. We considered E2F1 to
or decreases the transcriptional activity of target genes.be representative of the E2F family, and used adenovirus-
Five members of the E2F family have been isolatedmediated gene transfer to investigate the function of E2F1 to
show that overexpression of E2F1 promoted cell cycle progres- and named E2F1 to E2F5. The biological significance of
sion as measured by a flow cytometer. Furthermore, we investi- the complexity of the E2F family is presently unclear.
gated the effect of E2F1 overexpression to cyclin D1 and cyclin
However, the transcription activation capacity of E2F isE expression. Because we previously reported that the regula-
limited to the E2F1, E2F2, and E2F3, while E2F4 andtion of G1 cyclins is a key factor in the G1/S transition phase
in mesangial cells, we showed that overexpression of E2F1 E2F5 activate a limited number of target genes. These
induced protein expression of cyclin D1 and cyclin E and in- two subfamilies are differently regulated by the Rb fam-
creased promoter activity. Thus, we conclude that E2F1 plays ily protein and cyclin A. E2F1, E2F2, and E2F3 bind
an important role in the G1/S transition phase and acts on the
exclusively to pRb, whereas E2F4 and E2F5 bind primar-mesangial cell cycle through two distinct pathways: (1) E2F1
ily to p107 and p130 [7–9], and then their transcriptionaldirectly transcribes an S-phase gene, and (2) E2F1 pro-
motes cell cycle progression via the induction of cyclin D1 and activities are negatively regulated. In addition, E2F1,
cyclin E. E2F2, and E2F3 contain a cyclin-binding sequence in
the amino terminal portions of the proteins that mediates
the stable binding of cyclin A/CDK2. This interaction
The cell cycle of mammalian cells is regulated by a regulates the DNA-binding ability of the E2F/DP heter-
very complex machinery. The regulatory pathway involv- odimer by means of DP-1 phosphorylation [10–12],
ing the cyclin, cyclin-dependent kinases (CDKs), the Rb which decreases the transcriptional activity of E2F in the
tumor suppresser family, and the E2F family are consid- late G1 phase to S phase. E2F4 and E2F5 lack cyclin A
binding sites.
The E2F activity is critical for controlling the cell cycleKey words: E2F1 transcription factor, cell cycle progression, S phase
gene, cyclin D1 and E. progression not only in vitro but in vivo. Morishita et al
reported that the E2F decoy can inhibit proliferation of 1999 by the International Society of Nephrology
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smooth muscle cells and formation of vascular lesions the excessive proliferation of mesangial cells in glomeru-
lar disease.in vivo [13], which suggests that the E2F family plays an
To investigate whether or not the overexpression ofimportant role for the development of chronic prolifera-
E2F1 could promote the mesangial cell cycle, adenovi-tive disease. Although mesangial cell proliferation is im-
rus-mediated gene transfer was used. Overexpression ofportant for various proliferative glomerular diseases, the
E2F1 in rat mesangial cells increased thymidine uptakerole of the E2F family in the mesangial cell cycle remains
to 250% in the absence of FCS stimulation. Moreover,unclear. Our study examines the involvement of the E2F
using a flow cytometer, overexpression of E2F1 showedfamily in the mesangial cell cycle in order to understand
an increase in the percentage of S phase and G2/M phaseits regulation.
cells.
It can be concluded that the overexpression of E2F1
EXPRESSION OF THE E2F FAMILY IN RAT alone can promote the G1-S transition phase progress
MESANGIAL CELLS and increase mesangial cell proliferation. In other words,
E2F1 plays an critical role in the rat mesangial cell cycle.A variety of results have suggested that the transcrip-
tion factor E2F is a critical determinant of the G1/S
transition phase during the cell cycle in many cell lines, INDUCTION OF THE G1 CYCLINS, CYCLIN D1,
although the critical role of the E2F family in primary AND CYCLIN E BY E2F1 OVEREXPRESSION
culture cells or in chronic proliferative diseases is not
It is established that the E2F transcription factor bindsyet known.
to the promoter gene that is required for DNA replica-To determine whether or not the E2F family is in-
tion, and increases its expression in the G1/S phasevolved in mesangial cell proliferation and which of the
boundary. E2F binding sites are found not only in theE2F family members is important in mesangial cell pro-
promoters required for DNA synthesis, but also in cyclinliferation, the time course of protein expression of the
D1 and cyclin E promoters [18, 19].E2F family was examined in rat mesangial cells after
The transcriptional activity of E2F1 is directly regu-fetal calf serum (FCS) stimulation.
lated by binding to the Rb protein family, and indirectly
The protein expression of E2F1 through E2F3 was
regulates cyclin D1 and cyclin E through CDK activity
induced by FCS stimulation. There was a most dramatic
and phosphorylation of Rb protein (Fig. 1). To elucidate
change in E2F1 induction. The protein expression of the mechanisms of the E2F1-induced G1/S transition
E2F1 was not detected at all in the quiescent state, and phase, we investigated the role of E2F1 in the control
strongly increased from 12 hours after stimulation to of cyclin D1 and cyclin E expression.
reach its peak at 24 hours. Thus, we considered E2F1 to We transfected plasmids containing the cyclin D1 or
be a key factor of the G1/S transition phase in rat mesan- cyclin E promoter region with luciferase reporter gene
gial cells. to rat mesangial cells by electroporation methods. Then
The expression of E2F1 mRNA increased in parallel E2F1 protein was overexpressed by adenovirus-medi-
to the protein expression after FCS stimulation. ated gene transfer. Cyclin D1 and cyclin E promoter
activity was stimulated by E2F1 overexpression 5.7-fold
and 30-fold, respectively.CELL CYCLE PROGRESSION INDUCED BY
Western blot analysis showed that E2F1 overexpres-E2F1 OVEREXPRESSION IN RAT
sion induced the protein expression of cyclin D1 andMESANGIAL CELLS
cyclin E. These data suggest that E2F1 regulates cyclin
The proliferation of glomerular mesangial cells is con- D1 and cyclin E expression and strongly promotes the
sidered to be a fundamental problem of proliferative G1/S transition phase in the mesangial cell cycle.
glomerulonephritis. In the normal kidney, almost all
mesangial cells are in the quiescent state [14], but various
DISCUSSIONpathogenetic stimuli can induce their proliferation [15,
16]. In certain glomerular diseases, platelet-derived Proliferation of mesangial cells is induced as a re-
growth factor and a number of other growth factors are sponse to various mitogenic stimuli, and it advances the
produced in high quantity by invading inflammatory cells glomerular proliferative disease and eventually leads to
and mesangial cells. These growth factors have been renal failure. Studies have demonstrated that the activity
reported to stimulate cell cycle transition from the of specific cyclins, CDKs and CDK inhibitors changes
G0/G1 to the S phase [17]. It is important to understand during mesangial cell proliferation in the cell culture
what is most critical for the regulation of the G1/S transi- system and in vivo experimental models. The expression
tion phase, because it could lead to the rational design of cyclins D1, E, and A increases due to mitogenic stimu-
lation in cultured mesangial cells [20–24]. In the Thy1.1of novel pharmacotherapeutic approaches to suppress
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Fig. 1. Schematic of the mechanisms of the G1/S transition phase. Growth factor signals are followed by various intracellular signaling pathways
that increase the activity of cyclin D/CDK4 or CDK6 complexes. Cyclin D/CDK complexes facilitate phosphorylation of the Rb protein family
with the release of E2F. Then, E2F increases the expression of genes required for the G1/S transition phase, including cyclin D1 and cyclin E.
These cyclins also promote the phosphorylation of Rb protein and form an autoregulatory loop.
glomerulonephritis model, it was also shown that the mesangial cells compared with fibroblasts are terminally
differentiated and normally quiescent cells.expression of cyclin D1 and cyclin A increases consis-
In conclusion, we demonstrate that E2F1 plays a cen-tently with the onset of mesangial cell proliferation [25].
tral role in the mesangial cell cycle and promotes theE2F transcriptional factor is a target of these G1 cyclins
G1/S transition phase through two distinct pathways: (a)and promotes the G1/S transition phase (Fig. 1). We
induction of genes required for DNA synthesis, and (b)demonstrated that the expression of E2F1 through E2F3
control of the expression of cyclin D1 and cyclin E.increased by mitogenic stimulation, and overexpression
of especially E2F1 alone induced the proliferation of
ACKNOWLEDGMENTSmesangial cells.
Cyclins and E2F1 are critical for the mesangial cell We thank Dr. K. Ohtani for kindly providing E2F1 adenovirus and
plasmid. We also thank Dr. M. Eilers for kindly providing the plasmids.cycle, and it is important to understand the regulation
An abstract of this work was presented at the 1997 Annual Meetingand relationship of these cell cycle proteins. Ohtani, De-
of the American Society of Nephrology.
Gregori and Nevins reported that E2F1 induces cyclin
Reprint requests to Yoshio Terada, M.D., Second Department ofE, but not cyclin D1, expression and forms an autoregula-
Internal Medicine, Tokyo Medical and Dental University, 5-45, Yushimatory loop in rat embryo fibroblasts [19]. Our data show
1-chome, Bunkyo-ku, Tokyo 113, Japan.
that overexpression of E2F1 increases not only cyclin E E-mail: yterada.med2@med.tmd.ac.jp
expression, but cyclin D1 expression, and suggest that
there are at least two autoregulatory loops between E2F1 REFERENCES
and G1 cyclins in mesangial cells. We hypothesize that
1. Nevins JR: E2F: A link between the Rb tumor suppressor protein
mesangial cells need a large accumulation of G1 cyclins and viral oncoproteins. Science 258:424–429, 1992
2. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A:and E2F1 in order to progress the cell cycle, because
Inoshita et al: Cell cycle regulation by E2F1 1241
A cDNA encoding a pRB-binding protein with properties of the inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci
USA 92:5855–5859, 1995transcription factor E2F. Cell 70:337–350, 1992
14. Pabst R, Sterzel RB: Cell renewal of glomerular cell types in3. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ: Direct
normal rats: An autoradiographic analysis. Kidney Int 24:626–631,binding of cyclin D to the retinoblastoma gene product (pRb) and
1983pRb phosphorylation by the cyclin d-dependent kinase CDK4.
15. Abboud HE: Growth factors in glomerulonephritis. Kidney IntGenes Dev 7:331–342, 1993
43:252–267, 19934. Wu CL, Zukerberg LR, Ngwu C, Harlow E, Lees JA: In vivo
16. Couser WG, Johnson RJ: Mechanisms of progressive renal diseaseassociation of E2F and DP family proteins. Mol Cell Biol 15:2536–
in glomerulonephritis. Am J Kidney Dis 23:193–198, 19942546, 1995
17. Shankland SJ: Cell-cycle control and renal disease. Kidney Int5. La Thangue NB: DRTF1/E2F: An expanding family of heterodim-
52:294–308, 1997eric transcription factors implicated in cell-cycle control. Trends
18. Herber B, Truss M, Beato M, Muller R: Inducible regulatoryBiochem Sci 19:108–114, 1994 elements in the human cyclin D1 promoter. Oncogene 9:2105–2107,
6. Degregori J, Kowalik T, Nevins JR: Cellular targets for activation 1994
by the E2F1 transcription factor include DNA synthesis- and G1/ 19. Ohtani K, Degregori J, Nevins JR: Regulation of the cyclin E
S-regulatory genes. Mol Cell Biol 15:4215–4224, 1995 gene by transcription factor E2F1. Proc Natl Acad Sci USA
7. Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Xu G, Wydner 92:12146–12150, 1995
KL, Decaprio JA, Lawrence JB, Livingston DM: E2F-4, a new 20. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki
member of the E2F transcription factor family, interacts with p107. S, Marumo F: Overexpression of cell cycle inhibitors (p16INK4
Genes Dev 8:2665–2679, 1994 and p21Cip1) and cyclin D1 using adenovirus vectors regulates
8. Beijersbergen RL, Kerkhoven RM, Zhu L, Carlee L, Voor- proliferation of rat mesangial cells. J Am Soc Nephrol 8:51–60,
hoeve PM, Bernards R: E2F-4, a new member of the E2F gene 1997
family, has oncogenic activity and associates with p107 in vivo. 21. Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB: TGF-
b1-induced cell cycle arrest in renal mesangial cells involves inhibi-Genes Dev 8:2680–2690, 1994
tion of cyclin E-cdk 2 activation and retinoblastoma protein phos-9. Vairo G, Livingston DM, Ginsberg D: Functional interaction
phorylation. Kidney Int 51:1228–1236, 1997between E2F-4 and p130: Evidence for distinct mechanisms under-
22. Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M,lying growth suppression by different retinoblastoma protein fam-
Gordon KL, Roberts JM, Couser WG, Johnson RJ: Mesangialily members. Genes Dev 9:869–881, 1995
cell proliferation mediated by PDGF and bFGF is determined by10. Krek W, Xu G, Livingston DM: Cyclin A-kinase regulation of
levels of the cyclin kinase inhibitor p27Kip1. Kidney Int 51:1088–1099,E2F-1 DNA binding function underlies suppression of an S phase
1997checkpoint. Cell 83:1149–1158, 1995
23. Terada Y, Inoshita S, Nakashima O, Yamada T, Tamamori M,11. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG Jr,
Ito H, Sasaki S, Marumo F: Cyclin D1, p16, and retinoblastomaLivingston DM: Negative regulation of the growth-promoting
gene regulate mitogenic signaling of endothelin in rat mesangialtranscription factor E2F-1 by a stably bound cyclin A-dependent cells. Kidney Int 53:76–83, 1998protein kinase. Cell 78:161–172, 1994 24. Shankland SJ, Hamel P, Scholey JW: Cyclin and cyclin-depen-
12. Xu M, Sheppard KA, Peng CY, Yee AS, Piwnica-Worms H: dent kinase expression in the remnant glomerulus. J Am Soc
Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA- Nephrol 8:368–375, 1997
binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 25. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH,
14:8420–8431, 1994 Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ:
13. Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama Changes in cell-cycle protein expression during experimental mes-
M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: A gene therapy angial proliferative glomerulonephritis. Kidney Int 50:1230–1239,
1996strategy using a transcription factor decoy of the E2F binding site
